NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh for Potentially Curative Gene Therapy Candidate for Diabetes

Feb 11, 2020

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, today announced its entry into an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30.3 million people in the U.S., or 9% of the U.S. population. According to the update, Genprex’s licensed diabetes gene therapy technology is designed to reprogram alpha cells in the pancreas into beta-like cells, restoring their function, thereby replenishing insulin levels. “We are excited to announce the licensing agreement with The University of Pittsburgh, and we look forward to working with Dr. Gittes and his team to develop this groundbreaking treatment for diabetes,” Genprex’s Chairman and Chief Executive Officer Rodney Varner said in the news release. “At Genprex, we have always put patient needs first, focusing on ways to bring new treatment options to patient populations who have large unmet medical needs. We believe this diabetes gene therapy may potentially become a new treatment option for the millions of diabetes patients who now must take insulin replacement therapy, and it may be effective for patients who do not benefit sufficiently from that therapy. Even more moving, the diabetes gene therapy could hold the potential to provide long term effectiveness, or even be a cure, for diabetes patients.”

To view the full press release, visit http://nnw.fm/A5oN0

About Genprex, Inc.

Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and other serious diseases who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches for patients with cancer and other serious diseases. The company’s lead product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (“NSCLC”), uses the company’s unique, proprietary platform which delivers cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. In January 2020, the FDA granted Fast Track Designation for Oncoprex in combination with AstraZeneca’s Tagrisso(R) for the treatment of NSCLC. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]

NetworkNewsWire is part of the InvestorBrandNetwork.

More News

Torres Jewellery case: ED secures extradition of key accused from Romania
Nov 17, 2026
Torres Jewellery case: ED secures extradition of key accused from Romania

A three-member ED team escorted Zapichenko to Mumbai via the UAE, the agency said in a press statement. The Central Bureau of Investigation (CBI), India's nodal agency for Interpol-related matters, facilitated the extradition.

West Bengal government fine-tuning its Draft Startup policy, set to deploy a Special Purpose Vehicle
Nov 17, 2026
West Bengal government fine-tuning its Draft Startup policy, set to deploy a Special Purpose Vehicle

“West Bengal govt is fine-tuning its draft Start up policy and deploying a facilitator/entity which will work independently and provide all necessary support to all relevant stakeholders. The facilitator will work closely with the industry and educational institutions and all other stakeholders, in a bid to support the Startups,” Subrata Gupta, Chief Advisor to West Bengal Chief Minister said.

Zelenskiy says Ukraine struck Crimea bridge in response to Russian attacks on infrastructure
Nov 17, 2026
Zelenskiy says Ukraine struck Crimea bridge in response to Russian attacks on infrastructure

Ukraine launched a targeted drone and missile assault on the Crimea bridge in response to ongoing Russian attacks. President Volodymyr Zelenskiy stated that this operation was meticulously planned over several weeks by security forces. The operation involved the use of various drones and missiles, effectively hitting the bridge's road and rail sections. Prior to the attack, Ukrainian forces disabled critical Russian air defenses and electronic warfare equipment.

East Bengal, Mohun Bagan Join Hands As India Thumps Pakistan 2-1 To Claim 10th SAFF Title
Nov 17, 2026
East Bengal, Mohun Bagan Join Hands As India Thumps Pakistan 2-1 To Claim 10th SAFF Title

India defeated Pakistan 2-1 to secure a record-extending 10th SAFF Championship title.

Wayne Rooney Says He Considered Suicide During Manchester United Career
Nov 17, 2026
Wayne Rooney Says He Considered Suicide During Manchester United Career

Wayne Rooney revealed he contemplated suicide and struggled with alcohol and mental health during his successful playing career at Manchester United.

Ukraine says it hit 14 Russian ballistic missile launchers
Nov 17, 2026
Ukraine says it hit 14 Russian ballistic missile launchers

Ukraine is severely short of US-made ballistic missile interceptors, while Russia has stepped up attacks on energy infrastructure and logistics.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily World Feed

Get yourself immersed in engaging topics right here. Daily World Feed is a multi-platform media, providing you latest breaking news straight from the industry.

Sign Up